Company Overview and News

0
BFood to open at least 30 KRR outlets in India

2018-08-16 theedgemarkets
KUALA LUMPUR: Berjaya Food Bhd (BFood) is looking to strengthen its foothold in India with the opening of at least 30 Kenny Rogers Roasters (KRR) restaurants and 75 Jollibean kiosks via a partnership with an Indian firm.
5196

0
Berjaya Food signs MoU to further strengthen position in India

2018-08-15 malaymail
KUALA LUMPUR, Aug 15 — Berjaya Food (BFood) Bhd will further cement its presence in the Indian market with the opening of 30 Kenny Rogers Roasters (KRR) restaurants and 75 Jollibean kiosks through its development agent, World Iconic Brand (WIB) Hospitality Pvt Ltd India.
5196

0
BFood to expand Kenny Rogers Roasters' presence in India

2018-08-15 theedgemarkets
KUALA LUMPUR (Aug 15): Berjaya Food Bhd (BFood) will be opening at least 30 more Kenny Rogers Roasters (KRR) outlets and 75 Jollibean kiosks in India, via a partnership with World Iconic Brands (WIB) Hospitality Private Ltd inked today.
5196

0
Local equity market looks positive over next 12 months, says AmInvestment Research

2018-07-04 theedgemarkets
KUALA LUMPUR (July 4): The outlook for the local equity market looks positive for the next twelve to eighteen months, backed by steady economic growth, according to AmInvestment Bank Research.
5258 PBLOF 5196 7237 1295

0
T7 Global: We have not got any job from ECRL project

2018-06-28 thestar.com.my
It also pointed out that Tan Sri Vincent Tan was a passive investor in the company and that his divestment would not have any impact on its current business
7228 5196

0
Berjaya Food core franchise profit growth likely sustainale

2018-06-25 theedgemarkets
Berjaya Food Bhd (June 22, RM1.62) Maintain hold with a lower target price of RM1.74: Berjaya Food Bhd (BFood) reported a turnover of RM160 million, up 5.7% year-on-year (y-o-y), while core net profit surged 50% y-o-y to RM2.4 million for its fourth quarter of financial year 2018 (4QFY18). This brought its full-year FY18 core net profit to RM19.3 million — after stripping out one-off RM15.3 million loss from the disposal of Kenny Rogers Roasters (KRR) Indonesia — which disappointed both our and Bloomberg consensus expectations, at 93% and 87% of the respective forecasts.
5196

0
Starbucks to sustain Berjaya Food earnings growth — CIMB

2018-06-22 theedgemarkets
KUALA LUMPUR (June 22): CIMB Research said today Berjaya Food Bhd's Starbucks operations in Malaysia will continue to sustain Berjaya Food's earnings growth on expectation of 25 to 30 Starbucks outlets to be opened per year.
5196

0
Berjaya Food shares fall 1.2% despite profit return

2018-06-22 thestar.com.my
KUALA LUMPUR: Berjaya Food Bhd’s share price edges lower despite returning to the black in the fourth quarter ended April 30 on Starbucks boost.
5196

0
Trading ideas: Berjaya Food, Sapura Energy

2018-06-22 thestar.com.my
KUALA LUMPUR: Berjaya Food Bhd and Sapura Energy Bhd are among the stocks to watch on Friday following their latest news, according to JF Apex Research.
5196

4
Berjaya Food returns to black in fourth quarter

2018-06-21 thestar.com.my
Berjaya Food operates 91 KKR restaurants nationwide. It also operates 239 Starbucks coffee outlets in Malaysia and Brunei.
5196 BSMAF 1818

0
KLCI to remain under pressure, stay below 1,700 on rising global trade fears

2018-06-21 theedgemarkets
KUALA LUMPUR (June 22): The FBM KLCI is expected to remain under pressure today in line with the overnight fall at most global markets, and stay below the 1,700-point level.
5139 0900 9539 5196

0
Jag, BFood, Sapura Energy, XOX, Aeon Credit and Multi-Usage

2018-06-21 theedgemarkets
KUALA LUMPUR (June 21): Based on corporate announcements and news flow today, companies in focus on Friday (June 22) may include the following: Jag Bhd, Berjaya Food Bhd, Sapura Energy Bhd, XOX Bhd, Aeon Credit Service (M) Bhd and Multi-Usage Holdings Bhd.
5139 0900 9539 5196

0
Berjaya Food returns to black in 4Q on Starbucks boost

2018-06-21 theedgemarkets
KUALA LUMPUR (June 21): Berjaya Food Bhd returned to the black in the final quarter of its financial year 2018 with a net profit of RM837,000 against a net loss of RM3.37 million in the same quarter a year ago, as revenue improved with more Starbucks cafes in operation during the quarter.
5196

0
Tunku Shazuddin appointed Naza Italia chairman

2018-04-17 themalaymailonline
KUALA LUMPUR, April 17 — Naza Corporation Holdings today announced the appointment of Datuk Tunku Shazuddin Ariff Ibni Sultan Sallehuddin as chairman of its subsidiary Naza Italia Sdn Bhd.
5196

4
RHB Research positive on Berjaya Food

2018-03-16 themalaymailonline
At lunch break, Berjaya Food’s share price in Bursa Malaysia eased eight sen to RM1.75 with 241,800 shares traded. — Reuters picKUALA LUMPUR, March 16 — RHB Research is positive on food and beverages chain operator, Berjaya Food Bhd, on the back of sustainable growth driven by Starbucks through expansion of outlets and better consumer sentiment moving forward.
5196 BSMAF 1818

Related Articles

REPH: Recro Pharma Analysis and Research Report

1h - Asif

Overview Recro Pharma is a specialty pharmaceutical company that operates through two business divisions: an Acute Care division and a revenue-generating CDMO division. Each of these divisions are deemed to be reportable segments for financial reporting purposes. The company's Acute Care segment is primarily focused on developing and commercializing innovative products for hospital and related acute care settings. The company's lead product candidate is a proprietary injectable form of meloxicam, a long-acting preferential COX-2 inhibitor. IV meloxicam has successfully completed three Phase III clinical trials for the management of moderate to severe pain, consisting of two pivotal efficacy trials and a large double-blind Phase III safety trial, as well as other safety studies. Overall, the total new drug application, or NDA, program included over 1,400 patients. In late July 2017, the company submitted a NDA to the U.S. Food and Drug Administration, or FDA, for IV meloxicam...

ACHN: Achillion Pharmaceuticals Analysis and Research Report

1h - Asif

Overview Achillion Pharmaceuticals is a clinical-stage biopharmaceutical company focused on advancing its oral factor D inhibitors into late-stage development and commercialization. Each of the drug candidates in its oral factor D portfolio was discovered in its laboratories and is wholly owned by it. Achillion Pharmaceuticals is focusing its drug development activities on alternative pathway-mediated, rare diseases where there are no approved therapies or where existing therapies are inadequate for patients. To advance its investigational drugs into phase III and commercialization, the company plan to work closely with key stakeholders including patients, payors, regulators and healthcare professionals. The company's first-generation factor D inhibitor, ACH-4471, has demonstrated preliminary clinical proof-of-concept in patients with C3 glomerulopathy, or C3G, a disease affecting the kidney, and paroxysmal nocturnal hemoglobinuria, or PNH, a blood disorder, and has advanced...

BTE: Baytex Energy Trust Analysis and Research Report

2h - Asif

General Baytex Energy Corp. was incorporated on October 22, 2010 pursuant to the provisions of the ABCA. Baytex is the successor to the business of Baytex Energy Trust, which was transitioned to Baytex on December 31, 2010. Inter-Corporate Relationships The following table provides the name, the percentage of voting securities owned by it and the jurisdiction of incorporation, continuance, formation or organization of its material subsidiaries either, direct and indirect, as at the date hereof. ||Percentage of voting securities (directly or indirectly)|Jurisdiction of Incorporation/Formation| | ------------ | ------------: | :------------: | |Baytex Energy Ltd.|100%|Alberta| |Baytex Energy USA, Inc.|100%|Delaware| |Baytex Energy Partnership|100%|Alberta| Organizational Structure The following simplified diagram shows the inter-corporate relationships among it and its material subsidiaries as of the date hereof. <img src="https://www.sec.gov/A...